Introduction: A Crowded Stage Over the past quarter-century, the landscape of global health has undergone a seismic...
Reynand Wu
Novartis’s highly anticipated delpacibart etedesiran (del-desiran), a novel therapy acquired through its substantial investment in Avidity Biosciences,...
By Delilah Alvarado Published September 8, 2026 The biotechnology landscape experienced a seismic shift this week as...
The meteoric rise of GLP-1 receptor agonists—the class of drugs that includes blockbusters like Ozempic, Wegovy, and...
COPENHAGEN – In a significant move to reinforce global health architecture, the World Health Organization (WHO) and...
In April 2026, the American Society of Human Genetics (ASHG) convened its annual Industry Roundtable, a pivotal...
London, UK – A landmark international study, spearheaded by researchers at University College London (UCL), has unveiled...
ROCKVILLE, MD — In a move set to reshape the landscape of scientific dissemination, the American Society...
San Francisco, CA – December 12, 2023 – A groundbreaking new study, the WISDOM study, is poised...
This is the second installment in a new series where BioPharma Dive uses data visualization to recap...
